Low density lipoproteins (VLDL) by the liver are known to increase cholesterol levels, the study said. DNA, 1 week ago
Disruption of SVIP protein can lead to cardiovascular, fatty liver disease - News-Medical.Net, 1 week ago
Disrupting tiny liver protein can cause heart disease - Yahoo! India, 2 weeks ago
1 images for "vldl"
Dr. Robert Lustig's 2009 video " Sugar: The Bitter Truth ," has now garnered nearly 6.5 million views on YouTube. The featured video is a follow-up on that original lecture. In it, he discusses the metabolic influence of sugar and processed foods ...Sott.net, 17 hours ago
Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer
Pancreatic cancer is a highly malignant disease with a poor prognosis and it is essential to diagnose and treat the disease at an early stage. The aim of this study was to understand the underlying biochemical mechanisms of pancreatic ...RSC, 1 day ago
Patent Issued for Methods for Treating Disorders Or Diseases Associated with Hyperlipidemia and Hypercholesterolemia While Minimizing Side-Effects...
Patent Issued for Methods for Treating Disorders Or Diseases Associated with Hyperlipidemia and Hypercholesterolemia While Minimizing Side-Effects (USPTO 9364470) By a News Reporter-Staff News Editor at Heart Disease Weekly The Trustees of the ...Pharmacy Choice, 2 days ago Hypercholesterolemia Treatment Market, the Study Provides a Treatment Market by Segmenting the Market Based on Disease and Regions Analysis from 2016-2020 Digital Journal, 1 month ago Hypercholesterolemia Market 2016-2020 Industry exmined by Syndicate Market Research BioSpace, 1 month ago
Patent Issued for Thiazolidinediones of Omega-3 Polyunsaturated Acids as New Insulin Sensitizers for Treating Type2 Diabetes (USPTO 9364465)
By a News Reporter-Staff News Editor at Heart Disease Weekly Jiva Pharma, Inc (Ann Arbor, MI) has been issued patent number 9364465, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors (see also Jiva Pharma, Inc). ...Pharmacy Choice, 2 days ago Patent Issued for Ultra-Small ApoB-Containing Particles and Methods of Use (USPTO 9322833) Equities.com, 1 month ago Patent Issued for Reduced Dose Pharmaceutical Compositions of Fenofibrate (USPTO 9314447) Equities.com, 1 month ago Patent Application Titled "Food and Drink" Published Online (USPTO 20160095834) Equities.com, 2 months ago
Recent Studies from Hallym University Add New Data to Cholesterol (Validation of the Martin Method for Estimating Low-Density Lipoprotein Cholesterol...
Recent Studies from Hallym University Add New Data to Cholesterol (Validation of the Martin Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Korean Adults: Findings from the Korea National Health and Nutrition Examination ...) ...Equities.com, 2 days ago
Armenian government to create a fund to facilitate development of viticulture and winemaking YEREVAN, June 23. /ARKA/. The Armenian government has decided today to set up the Fund for Development of Viticulture and Winemaking to build on the ...Groong, 3 days ago
Researchers from Kaohsiung Medical University Hospital Report New Studies and Findings in the Area of Atrial Fibrillation (VLDL from Metabolic...
Researchers from Kaohsiung Medical University Hospital Report New Studies and Findings in the Area of Atrial Fibrillation (VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to ...) By a ...4 Traders, 1 week ago
Northville, MI-based Gemphire Therapeutics (GEMP) is set for its IPO of 3.74M shares of common stock at $11 - 13. The clinical-stage biopharmaceutical firm develops therapies to treat dyslipidemia, elevated low-density lipoprotein cholesterol ...Seeking Alpha, 1 week ago
Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Patients With Type 2 Diabetes and Persistent High Triglycerides
) - Amarin Corporation plc (NASDAQ: AMRN) today announced additional data on Vascepa (icosapent ethyl) presented at the annual meeting of the American Diabetes Association (ADA) supporting its efficacy in reducing concentrations of potentially ...Sys-Con Belgium, 2 weeks ago AMARIN : Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Patients With Type 2 Diabetes and Persistent High Triglycerides 4 Traders, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!